Haemoglobin A1c analysis in the management of patients with diabetes: From chaos to harmony

Journal of Clinical Pathology

Volumn 61, Issue 9, 2008, Pages 983-987

  Berg, A H ^a   Sacks, David B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

ACCURACY; CALIBRATION; CHROMATOGRAPHY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC PATIENT; DIAGNOSTIC PROCEDURE; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNODETECTION; INSULIN DEPENDENT DIABETES MELLITUS; ION EXCHANGE CHROMATOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK FACTOR; SCREENING TEST; STANDARDIZATION; BLOOD; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; SENSITIVITY AND SPECIFICITY;

EID: 51349167788     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2007.049205     Document Type: Review

References (53)

1. World Health Organization. Fact sheet no. 312, September 2006. http://www.who.int/mediacentre/factsheets/fs312/en/(accessed 1 May 2008).
2. Sacks DB, Bruns DE, Goldstein DE, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436-72.
3. Goldstein DE, Little RR, Lorenz RA, et al. Tests of glycemia in diabetes. Diabetes Care 2004;27:1761-73.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
6. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53.
7. Kunkel HG, Wallenius G. New hemoglobin in normal adult blood. Science 1955;122:288.
8. Allen DW, Schroeder WA, Balog J. Observations on the chromatographic heterogeneity of normal adult and fetal human hemoglobin: a study of the effects of crystallization and chromatography on the heterogeneity and isoleucine content. J Am Chem Soc 1958;80:1628-34.
9. Gabbay KH, Hasty K, Breslow JL, et al. Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab 1977;44:859-64.
10. Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun 1969;36:838-43.
11. Trivelli LA, Ranney HM, Lai HT. Hemoglobin components in patients with diabetes mellitus. N Engl J Med 1971;284:353-7.
12. 1c. Biochem Biophys Res Commun 1975;67:103-9.
13. Stratton IM, Adler Al, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.
14. 1c separation by isoelectric focusing. Am J Hematol 1978;4:367-74.
15. 1c. Diabetes 1978;27:102-7.
16. Poynard JP, Malgrange D, Couchot J, et al. [Micromethod determination of hemoglobin Alc in diabetics. Preliminary results]. Nouv Presse Med 1978;7:1648-9.
17. Boucher BJ, Burrin JM, Gould BJ, et al. A collaborative study of the measurement of glycosylated haemoglobin by several methods in seven laboratories in the United Kingdom. Diabetologia 1983;24:265-71.
18. Sacks DB. Carbohydrates. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz textbook of clinical chemistry and molecular diagnostics. 4th edn. St Louis: Elsevier Saunders, 2006:837-902.
19. 1c: analysis and standardisation. Clin Chem Lab Med 2003;41:1199-212.
20. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001;47:153-63.
21. 1c analysis: problem solved? Clin Chem 2003;49:1245-7.
22. Fluckiger R, Woodtli T, Berger W. Quantitation of glycosylated hemoglobin by boronate affinity chromatography. Diabetes 1984;33:73-6.
23. 1c. Clin Chem 1997;43:511-7.
24. Little RR, Wiedmeyer HM, England JD, et al. Interlaboratory standardization of measurements of glycohemoglobins. Clin Chem 1992;38:2472-8.
25. Weykamp CW, Penders TJ, Miedema K, et al. Standardization of glycohemoglobin results and reference values in whole blood studied in 103 laboratories using 20 methods. Clin Chem 1995;41:82-6.
26. Stott A, Casson IF, Higgins GJ. Glycated haemoglobin assays. Approaches to standardization of results. Diabet Med 2001;18:274- 9.
27. Gerlo E, Gorus F. Calibration of ion-exchange HPLC measurements of glycohemoglobin: effect on interassay precision. Clin Chem 1997;43:2353-7.
28. Benjamin RJ, Sacks DB. Glycated protein update: implications of recent studies, including the diabetes control and complications trial. Clin Chem 1994;40:683-7.
29. College of American Pathologists. Electrophoresis/chromatography survey, 1993, Set EC-C. Northfield, Illinois: College of American Pathologists.
30. 1c in Japan using the new reference material in routine clinical assays. Ann Clin Biochem 2005;42:47-50.
31. 1c. I: Comparison of Japan Diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories. Ann Clin Biochem 2005;42:41-6.
32. Tominaga M, Kobayashi I, Kuwa K. Sixth glycohemoglobin accuracy control survey. J Jap Diabetes Soc 2001;44:283-6.
33. Little RR, Rohlfing CL, Wiedmeyer HM, et al. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001;47:1985-92.
34. National Glycohemoglobin Standardization Program. http://www.ngsp.org/prog/protocol/prot.html (accessed 6 May 2008).
35. Steffes M, Cleary P, Goldstein D, et al. Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. Clin Chem 2005;51:753-8.
36. College of American Pathologists. Survey Data, 2007 GH2-A. http://www.ngsp.org/prog/index.html (accessed 6 May 2008).
37. Arnquist H, Wallensteen M, Jeppsson JO. Standardization of longterm glucose measurements established. Lakartidningen 1997;50:4789-90.
38. 1c,/glycohemoglobin determinations. J Int Fed Clin Chem 1996;9:62-4, 6-7.
39. 1c based on peptide mapping. Clin Chem 1997;43:1944-51.
40. 1c in human blood. Clin Chem Lab Med 2002;40:78-89.
41. 1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004;50:166-74.
42. 1c determination. Diabetologia 2004;47:1143-8.
43. 1c: a comparison of NGSP with IFCC transformed values. Clin Chim Acta 2005;358:81-6.
44. 1c. Clin Chem 2005;51:681-3.
45. 1c measurement. Diabetes Care 2007;30:2399-400.
46. Little RR. Glycated hemoglobin standardization - National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med 2003;41:1191-8.
47. 1c) and average blood glucose: can HbA1c be reported as estimated blood glucose concentration [editorial]? J Diabetes Sci Technol 2007;1:801-3.
48. Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med 2007;24:333-43.
49. Yoshinaga H, Kosaka K. High glycosylated hemoglobin levels increase the risk of progression to diabetes mellitus in subjects with glucose intolerance. Diabetes Res Clin Pract 1996;31:71-9.
50. 1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey. Diabetes Res Clin Pract 2007;76:251-6.
51. Standards of medical care in diabetes - 2007. Diabetes Care 2007;30(Suppl 1):S4-41.
52. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med 2006;23:579-93.
53. American Association of Clinical Endocrinologists. Medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13(Suppl 1):1-68.